Bp PLC Amgen Inc Transaction History

Bp PLC

  • $13.2 Million
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$212.27 - $248.7 $13.9 Million - $16.3 Million
-65,479 Closed
0 $0
Q2 2021

Aug 09, 2021
SELL
$233.58 - $259.14 $2.99 Million - $3.32 Million
-12,802 Reduced 16.35%
65,479 $16 Million
Q1 2021

May 13, 2021
SELL
$221.91 - $258.6 $2.21 Million - $2.57 Million
-9,949 Reduced 11.28%
78,281 $19.5 Million
Q4 2020

Feb 08, 2021
SELL
$216.38 - $257.67 $5.11 Million - $6.09 Million
-23,626 Reduced 21.12%
88,230 $20.3 Million
Q3 2020

Oct 30, 2020
BUY
$234.65 - $260.95 $12.4 Million - $13.8 Million
53,056 Added 90.23%
111,856 $28.4 Million
Q2 2020

Aug 05, 2020
SELL
$197.81 - $242.74 $435,182 - $534,028
-2,200 Reduced 3.61%
58,800 $13.8 Million
Q4 2019

Feb 07, 2020
SELL
$189.21 - $243.2 $113,526 - $145,920
-600 Reduced 0.97%
61,000 $14.7 Million
Q3 2019

Nov 13, 2019
SELL
$174.11 - $208.62 $417,864 - $500,688
-2,400 Reduced 3.75%
61,600 $11.9 Million
Q2 2019

Jul 29, 2019
SELL
$166.7 - $195.41 $7.5 Million - $8.79 Million
-45,000 Reduced 41.28%
64,000 $11.8 Million
Q1 2019

May 08, 2019
BUY
$180.87 - $203.88 $1.63 Million - $1.83 Million
9,000 Added 9.0%
109,000 $20.7 Million
Q2 2018

Jul 30, 2018
SELL
$166.05 - $186.51 $2.49 Million - $2.8 Million
-15,000 Reduced 13.04%
100,000 $18.5 Million
Q1 2018

Apr 26, 2018
BUY
$169.43 - $198.0 $5.25 Million - $6.14 Million
31,000 Added 36.9%
115,000 $19.6 Million
Q4 2017

Feb 06, 2018
SELL
$168.79 - $188.59 $337,580 - $377,180
-2,000 Reduced 2.33%
84,000 $14.6 Million
Q3 2017

Oct 30, 2017
BUY
$167.29 - $191.0 $14.4 Million - $16.4 Million
86,000
86,000 $16 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bp PLC Portfolio

Follow Bp PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

News

Stay updated on Bp PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email